VSee EBITDA from 2010 to 2024

VSEEW Stock   0.06  0.02  26.20%   
VSee Health, EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, VSee Health, EBITDA regression line of quarterly data had r-squared of  0.47 and coefficient of variation of (1,607). View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-1.2 M
Current Value
-1.1 M
Quarterly Volatility
603.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check VSee Health, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VSee Health,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 449.8 K, Interest Expense of 38.5 K or Selling General Administrative of 6.6 M, as well as many indicators such as Price To Sales Ratio of 24.94, Dividend Yield of 0.0 or Days Sales Outstanding of 22.23. VSee financial statements analysis is a perfect complement when working with VSee Health, Valuation or Volatility modules.
  
Check out the analysis of VSee Health, Correlation against competitors.
For more information on how to buy VSee Stock please use our How to Invest in VSee Health, guide.

Latest VSee Health,'s EBITDA Growth Pattern

Below is the plot of the Ebitda of VSee Health, over the last few years. It is VSee Health,'s EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VSee Health,'s overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (1.31 M)10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

VSee EBITDA Regression Statistics

Arithmetic Mean(37,530)
Coefficient Of Variation(1,607)
Mean Deviation465,274
Median253,266
Standard Deviation603,121
Sample Variance363.8B
Range1.6M
R-Value(0.69)
Mean Square Error206.3B
R-Squared0.47
Significance0
Slope(92,793)
Total Sum of Squares5.1T

VSee EBITDA History

2024-1.1 M
2023-1.2 M
2022-1.3 M

About VSee Health, Financial Statements

VSee Health, investors use historical fundamental indicators, such as VSee Health,'s EBITDA, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in VSee Health,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-1.2 M-1.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for VSee Stock Analysis

When running VSee Health,'s price analysis, check to measure VSee Health,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VSee Health, is operating at the current time. Most of VSee Health,'s value examination focuses on studying past and present price action to predict the probability of VSee Health,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VSee Health,'s price. Additionally, you may evaluate how the addition of VSee Health, to your portfolios can decrease your overall portfolio volatility.